Recombinant polypeptides having Ph1 p I epitope antigenicity and methods of diagnosing allergy in vitro
A recombinant DNA molecule comprising a nucleotide sequence (I) which codes for a polypeptide displaying the antigenicity of one, two or more of the Phl p I epitope clones (28, 34, 41, 42, 43, 45, 50, 52, 64, 80, 85, 86, 95, 97, 98, 103, 108, 109, 113, 114), with the amino acid sequences defined in SEQ ID NOS: 5, 7, 9 and 12–28, and preferably being derived from grasses or monocotyledonic plants, or a nucleotide sequence (II) which hybridizes with such a nucleotide sequence (I) under conditions of high, stringency. Polypeptides displaying the antigenicity of one, two or more of the Phl p I epitope clones (28, 34, 41, 42, 43, 50, 52, 64, 80, 85, 86, 95, 97, 98, 103, 108, 109, 113, 114). Recombinant expression vectors containing the recombinant molecule and host cells transformed with the vector. Diagnostic methods based on utilizing the polypeptides in immunoassays for humoral antibodies and cellular reactions.
1. A recombinant polypeptide displaying the antigenicity of at least one of the Phl p I epitopes defined by the amino acid sequences given in clones 28 (SEQ ID NO: 26), 34 (SEQ ID NO: 15), 41 (SEQ ID NO: 24), 42 (SEQ ID NO: 27), 43 (SEQ ID NO: 14), 45 (SEQ ID NO: 13), 50 (SEQ ID NO: 18), 52 (SEQ ID NO: 28), 64 (SEQ ID NO: 20), 80 (SEQ ID NO: 5), 85 (SEQ ID NO: 22), 86 (SEQ ID NO: 23), 95 (SEQ ID NO: 17), 97 (SEQ ID NO: 7), 98 (SEQ ID NO: 9), 103 (SEQ ID NO: 19), 108 (SEQ ID NO: 25), 109 (SEQ ID NO: 21), 113 (SEQ ID NO: 12), and 114 (SEQ ID NO: 16).
2. A polypeptide according to claim 1 in which the polypeptide is fused to an additional polypeptide.
3. A polypeptide according to claim 2 wherein said additional polypeptide is β-galactosidase, GST or lambda cII protein or any other polypeptide that can be expressed as a fusion protein in prokaryotic or eukaryotic cells.
4. A polypeptide according to claim 1 , in which the peptide is conjugated covalently to an analytically detectable group.
5. A polypeptide according to claim 1 , in which the peptide is linked to a water-insoluble phase by physical adsorption or a covalent bond.
6. Method of in vitro diagnosing allergy to plant protein in a patient which comprises contacting a body fluid sample, suspected of containing IgE antibody against the plant protein, with a polypeptide according to any one of claims 1 – 3 under conditions permitting the formation of a complex containing IgE antibody and the polypeptide, whereafter the complex is measured and related to the amount of the IgE antibody in the sample, an elevated level being taken as an indication of allergy against a plant protein comprising the polypeptide.